Article History
Received: 29 July 2024
Accepted: 29 August 2024
First Online: 19 September 2024
Declarations
:
: Dr Luttrull: Ojai Retinal Technologies LLC; managing member, equity. Replenish, Inc.: equity. Dr Tzekov: No conflicts to disclose. Dr Bhavan: No conflicts to disclose.
: All study data were de-identified prior to analysis. As this study is retrospective and limited to the analysis of de-identified patient data, informed consent from patients was neither required nor obtained, and exempted from approval by the Western Investigational Review Board (WCG IRB). The study adhered to the Health Insurance Portability and Accountability Act and Helsinki Declaration for Medical Research.